Christopher Salerno to Adult
This is a "connection" page, showing publications Christopher Salerno has written about Adult.
Connection Strength
0.327
-
Ventricular assist device using a thoracotomy-based implant technique: Multi-Center Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical Techniques Other Than Full Median Sternotomy (HM3 SWIFT). J Thorac Cardiovasc Surg. 2024 Nov; 168(5):1474-1484.e12.
Score: 0.055
-
Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant. 2014 Aug; 33(8):809-15.
Score: 0.028
-
[Comparison of the leukaemia incidence in two cohorts of farmers and traders in the Vercelli province of Italy, 2002-2009]. Ann Ig. 2011 Jan-Feb; 23(1):27-32.
Score: 0.022
-
Open-chest management after heart transplantation. Tex Heart Inst J. 2006; 33(3):306-9.
Score: 0.016
-
Clinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry. Circulation. 2025 Apr; 151(13):896-909.
Score: 0.015
-
The Society of Thoracic Surgeons Intermacs 2024 Annual Report: Focus on Outcomes in Younger Patients. Ann Thorac Surg. 2025 01; 119(1):34-58.
Score: 0.014
-
Cost effectiveness of commercial portable ex vivo lung perfusion at a low-volume US lung transplant center. Artif Organs. 2024 Nov; 48(11):1288-1296.
Score: 0.014
-
Increasing Utilization of Extended Criteria Donor Hearts for Transplantation: The OCS Heart EXPAND Trial. JACC Heart Fail. 2024 Mar; 12(3):438-447.
Score: 0.014
-
Transplantation Outcomes with Donor Hearts after Circulatory Death. N Engl J Med. 2023 06 08; 388(23):2121-2131.
Score: 0.013
-
Outcomes in Smaller Body Size Adults After HeartMate 3 Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2022 12; 114(6):2262-2269.
Score: 0.012
-
Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: A retrospective multicenter study. J Thorac Cardiovasc Surg. 2022 06; 163(6):2107-2116.e6.
Score: 0.011
-
The Society of Thoracic Surgeons Intermacs 2019 Annual Report: The Changing Landscape of Devices and Indications. Ann Thorac Surg. 2020 03; 109(3):649-660.
Score: 0.010
-
Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg. 1999 Jun; 117(6):1063-9.
Score: 0.010
-
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 04 25; 380(17):1618-1627.
Score: 0.010
-
Bleeding Complication Rates Are Higher in Females after Continuous-Flow Left Ventricular Assist Device Implantation. ASAIO J. 2018 Nov/Dec; 64(6):748-753.
Score: 0.010
-
Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. Circulation. 2018 10 30; 138(18):1923-1934.
Score: 0.010
-
Surgical therapy for pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg. 1998 May; 65(5):1415-9.
Score: 0.009
-
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Apr 12; 378(15):1386-1395.
Score: 0.009
-
Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support. J Card Fail. 2017 Dec; 23(12):852-858.
Score: 0.009
-
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med. 2017 02 02; 376(5):440-450.
Score: 0.008
-
Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes. J Card Fail. 2016 Dec; 22(12):981-987.
Score: 0.008
-
Factors Related to Pump Thrombosis With the Heartmate II Left Ventricular Assist Device. J Card Surg. 2015 Oct; 30(10):775-80.
Score: 0.008
-
Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. J Thorac Cardiovasc Surg. 2014 Feb; 147(2):581-9; discussion 589.
Score: 0.007
-
The effect of changing presentation and management on the outcome of blunt rupture of the thoracic aorta. J Thorac Cardiovasc Surg. 2006 Mar; 131(3):594-600.
Score: 0.004